When we talk about innovation in healthcare, it’s easy to think about labs, investors, and technology roadmaps. But some of the most transformative breakthroughs start not in a research center or boardroom, but at the bedside—where a patient’s life is on the line.
That’s where Dr. Todd Rosengart, a thoracic surgeon and Chair of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, has spent decades. And it’s where he saw one of the ICU’s deadliest and least predictable complications—aspiration pneumonia—play out again and again.
“Every clinician has frustrations they carry with them,” Dr. Rosengart reflected. “For me, aspiration pneumonia has always been one of those vexing, silent killers. You could do everything right for a patient, and then watch them suffer from a complication no one could see coming.”
Rather than accept that reality, Dr. Rosengart began searching for a solution—one that could finally give clinicians a way to see aspiration risk before it struck.
From Bedside Insight to Big Idea
Aspiration pneumonia is particularly dangerous in ICU patients because it can strike without warning. Rosengart recognized that when the stomach swells, pressure can push harmful contents back up the esophagus creating the perfect conditions for aspiration to occur.
His idea: use ultrasound in a novel, non-invasive way to monitor gastric distension—essentially creating an early warning system for a silent, deadly problem. He filed intellectual property early, collected proof-of-concept data, and began to map what a clinical solution could look like.
“Being a surgeon teaches you to act,” Rosengart said. “If you see a problem, you fix it. That mentality carried over into innovation for me—I wanted to find a way to prevent aspiration before it harmed another patient.”
The Power of Partnership
Ideas like this don’t become companies on their own. That’s where the community around TMC Innovation plays a critical role.
Enter Zaffer Syed, an experienced medical device operator who, during his time as an Entrepreneur-in-Residence (EIR) at TMC Innovation, came across Rosengart’s work. Today, Zaffer is the CEO of Aspira Medical.
“When I was an EIR, my job was to find promising ideas and vet their commercial potential,” Zaffer explained. “When I saw Dr. Rosengart’s IP, I knew it was special—it addressed a massive unmet need, had early proof-of-concept data, and most importantly, came from a clinician who had experienced the problem firsthand.”
What began as part-time consulting evolved quickly. With Baylor and TMC Innovation’s support, Zaffer helped license the IP, raised early funds, and moved device development forward. Before long, he stepped in as CEO, launching the company that became Aspira Medical.
Building Aspira Medical
Aspira’s solution is a small, wearable ultrasound patch that continuously tracks changes in stomach dimension in ICU patients. The vision: give clinicians a way to identify aspiration risk early—before it turns into pneumonia.
From early bench testing to licensing IP from Baylor, raising capital from angels and institutional partners, and engaging the FDA for feedback, the Aspira Medical team has been steadily advancing. Their goal: move toward FDA submission in the next two years.
“It’s rare to see this kind of alignment,” Zaffer noted. “You have world-class clinical insight, strong institutional support, and a committed innovation ecosystem all pulling together. That combination is what makes Aspira Medical possible.”
Clinicians as Entrepreneurs
For Rosengart, Aspira Medical isn’t his first entrepreneurial endeavor. He has co-founded ventures in gene therapy and digital health, and he understands the unique challenges of translating science into scalable companies. But what makes this story compelling is the reminder that the best innovations are grounded in patient experience.
“The real measure of innovation isn’t how clever the technology is—it’s whether it actually solves the problems patients and clinicians face every day,” Rosengart said.
At TMC Innovation, we’ve seen time and again that when you pair clinician insight with entrepreneurial expertise, you create the conditions for transformative solutions. Aspira Medical is a prime example: a surgeon’s determination to fix a problem, matched with an entrepreneur’s drive to build a company.
Beyond the Scalpel
Aspira Medical is more than a new device. It represents what happens when our ecosystem does what it was designed to do: connect the right people, align resources, and move ideas from bedside to market.
Clinicians like Dr. Rosengart step beyond the scalpel to take on the risks of entrepreneurship because they know what’s at stake for their patients. And entrepreneurs like Zaffer lean in because they see the potential to build something with global impact.
At TMC Innovation, we’ve seen time and again that the most transformative health tech startups emerge when clinician insight meets entrepreneurial expertise. Engaging physicians early and often ensures solutions are not only innovative, but practical and impactful at the bedside.
Are you a clinician interested in shaping the next generation of healthcare solutions?